ARCHIVES

ImClone Offered C225 Deal To Seven Firms Prior To BMS

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Nutrition Research Priority Areas Outlined By NCI

December 6, 1974

Guest Editorial By Gregory Reaman: Memories Of A Merger Past

July 15, 2011

Includes June issue of Business & Regulatory Report.

June 28, 2002

DCT T Consider Reissuing RFA For Surgical Oncology

March 4, 1983

NCI-Approved Clinical Trials

October 29, 2004

ACS Professors; Connie Mack Is Chairman Of Moffitt Board.

February 9, 2001